Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuralgia × Electroacupuncture × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Breast Neoplasms 5 Vomiting 3 Prostatic Neoplasms 3 Pain 3 Nausea 3 Sleep Initiation and Maintenance Disorders 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Acupuncture 2 Xerostomia 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Testicular Neoplasms 1 Teratoma 1 Sarcoma 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Prostatic Hyperplasia 1 Postoperative Ileus 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Opioid-Induced Constipation 1 Obesity, Abdominal 1 Obesity 1

Interventions

Pregabalin 4 Lidocaine 4 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 onabotulinum toxin A 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Thalidomide 1 Telmisartan 1 Surveys and Questionnaires 1 Sodium Chloride 1 Saline Solution 1 Paclitaxel 1 Oxycodone 1 Oxaliplatin 1 Low-Level Light Therapy 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hospitals 1 Geritol 1 Gabapentin 1 Folfox protocol 1 Exercise Therapy 1 Exercise 1 Electroacupuncture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡